Clinical Trial Update: A Study to Monitor the Safety of Enzalutamide in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 study updating safety observations of enzalutamide in men with progressive castration-resistant prostate cancer previously treated with docetaxel.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Enzalutamide (enzalutamide)

Snippet

Sponsor: Astellas Pharma Europe B.V. | Conditions: Castration-Resistant Prostate Cancer, Prostate Cancer | Phase 2 | Status: COMPLETED